We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Doctors from across the world gathered at ...
Leda Mannent, MD, global project head, Immunology and Inflammation, Sanofi, outlines future steps for the clinical development of rilzabrutinib, as well as promising data to advance to phase 3 studies ...
Location: San Diego Convention Center, Room 31A-C (Upper Level) Additionally, the poster presentation will be available as an ePoster on the ATS 2024 International Conference website, and will be ...
Type 2 inflammation influences the severity of post-acute sequelae of SARS-CoV-2, highlighting the need for targeted interventions. Innovative therapies like ALIS, tezepelumab, and dupilumab show ...
MORRISVILLE, N.C., May 10, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today the company will present data related to the investigational use of L606 (liposomal treprostinil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results